Home » Topics » BioWorld

BioWorld
RSS

CTI RAISES $38.5 MILLION

Nov. 30, 1992

INSECTS FIGHT BACK AGAINST BT TOXIN

Nov. 30, 1992

EUROPEAN PATENT DISCLOSURES

Nov. 30, 1992

COLLAGEN RAISES $15M IN TARGET OFFERING

Nov. 30, 1992

SHUTTLE TO TEST EFFECTS OF SPACE ON CELLS

Nov. 25, 1992

CYTEL CHANGES RESEARCH FOCUS

Nov. 25, 1992

CORTECH ANNOUNCES IPO

Nov. 25, 1992

U.N. CONDUCTS BIODIVERSITY POLL

Nov. 25, 1992

ALAMAR DEVELOPS NON-TOXIC DYE

Nov. 25, 1992

COLLAGEN RESPONDS TO HOUSE COMMITTEE REPORT

Nov. 24, 1992

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...